Antibiotics

Newest Oldest Showing 1-9 of 9 results
Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Analysis of the Prophylactic use of Hydroxychloroquine at the Beginning of the COVID-19 Pandemic Among Physicians

Mehmet Gökhan Gönenli and others

Healthcare workers were on the front line of the global effort against COVID-19. Thousands of physicians died from COVID-19 in many countries. In addition, difficulties in accessing personal protective equipment (PPE), lack of training, and workforce shortages have exposed the vulnerability of healthcare workers who desperately sought other options to protect (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey

Yeliz Tanrıverdi-Çaycı and others

Urinary tract infections (UTIs) are seen in all age groups and are among the most frequent bacterial infections. Enterobacterales are the most common bacterial species that cause UTIs . Escherichia coli is the most common cause of both complicated UTIs (65%) and uncomplicated UTIs (75%). E. coli is followed by other Enterobacterales such as Klebsiella spp., Proteus spp., and Serratia spp. Resistance of urinary tract pathogens to (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Antibiotic Use among Patients Hospitalized with COVID-19 and Treated in Three Different Clinics

Oğuz Evlice and others

The clinical spectrum of COVID-19 varies, ranging from asymptomatic infection to critical illness. The most commonly used tool for the classification of disease severity is the National Institute of Health (NIH) severity scale, which has four categories: mild, moderate, severe, and critical. Patients with moderate and severe clinical courses are followed up in wards, while those with (...) Read More

Original Article / VOLUME 4, ISSUE 1, MARCH 2022

ANTIBACDUS-PAN: Antibacterial Utilization among Adult Patients Before and During COVID-19 Pandemic within 12-Months Period: A Tertiary Hospital Pharmacoepidemiology Study

Ege Anıl Uçar and others

Rational use of medicines (RUM) has been a concern worldwide for half a century, and is of great importance, given that almost half of all prescribed drugs are irrational. The irrational use of drugs can be disastrous and may cause adverse events, creating a (...) Read More

Letter to the Editor / VOLUME 2, ISSUE 3, DECEMBER 2020

Contaminated Generic Non-approved Remdesivir Vials: New Risk in Treatment of COVID-19

Gökhan Aygün and others

Remdesivir is a novel nucleotide analogue antiviral drug with in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1). Food and Drug Administration (FDA) and Drug Controller General of India have authorized the emergency use for the treatment of COVID-19 under an Read More

Original Article / VOLUME 1, ISSUE 3, DECEMBER 2019

Public Knowledge and Attitudes Regarding Antibiotic Use in Ankara, Turkey

Alpay Azap and others

The discovery of antibiotics has been a milestone for the treatment of infectious diseases. However, soon after antimicrobials came into use, it has been recognized that microorganisms become resistant. Antimicrobial resistance decreases the number of treatment options available in infectious diseases. Currently, antimicrobial resistance has become an issue […] Read More

Original Article / VOLUME 1, ISSUE 2, AUGUST 2019

Pattern of Antibiotic Prescriptions in Dentistry in Turkey: Population Based Data from the Prescription Information System

Mehtap Aydın and others

Antibiotics are the most widely prescribed drugs in dentistry. Irrational use of antibiotics (IUA) is common in Turkey and other countries. However, IUA leads to the development of antibiotic resistance, which can significantly affect the quality health care and increase the cost. Emerging [...] Read More